Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
MedPlus Health Services
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Diagnostics Expansion And Private Labels Will Strengthen Market Position
Key Takeaways Strategic expansion and private label focus aim to boost revenue, profit margins, and market penetration through increased store network and product diversification. Operational efficiencies from warehouse additions and a disciplined network increase scalability, supporting long-term sustainable growth and earnings.
View narrative
₹1.06k
FV
22.8% undervalued
intrinsic discount
12.69%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
about 1 month ago
author updated this narrative
New Hope
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Bengalla And Maxwell Growth Will Drive Production Amid Margin Risks
Key Takeaways Strong coal demand and supply constraints boost pricing power, supporting resilient earnings and profitability as New Hope expands low-cost production. Prudent capital management and mine ramp-ups drive free cash flow and enhance shareholder returns, positioning the company for sustained performance.
View narrative
AU$4.16
FV
4.9% overvalued
intrinsic discount
2.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
38
users have followed this narrative
3 months ago
author updated this narrative
Caleres
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Brick-and-mortar Weakness Will Persist As Digital Transitions Will Offer Hope
Key Takeaways Slow adaptation to digital and e-commerce trends, along with reliance on legacy brands, threatens market share, margins, and long-term profitability. Ongoing supply chain pressures, consumer spending weakness, and rising sustainability demands increase the risk of earnings erosion and reputational damage.
View narrative
US$14.00
FV
10.8% overvalued
intrinsic discount
-0.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative
NTT
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Rising Capital Expenditures And Japan's Aging Market Will Pressure Performance
Key Takeaways Reliance on asset sales and exposure to Japan's demographic decline threaten future profit stability and constrain long-term revenue growth. Rising investment costs, intense competition, and uncertain integration benefits jeopardize margins and sustainable earnings.
View narrative
JP¥150.00
FV
8.6% overvalued
intrinsic discount
2.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative
FedEx
AN
AnalystLowTarget
Consensus Narrative from 30 Analysts
Digitalization And Rising Costs Will Undermine Future Viability
Key Takeaways Structural declines in parcel volumes, rising labor and environmental costs, and intensifying price competition threaten long-term revenue growth and margin sustainability. Underperformance in international markets and challenges from e-commerce giants could significantly limit global expansion and erode pricing power.
View narrative
US$206.04
FV
14.9% overvalued
intrinsic discount
3.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative
TTS (Transport Trade Services)
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Danube Flows And Digitized Logistics Will Fuel Maritime Resilience
Key Takeaways Strategic investments in vertical integration and logistics are strengthening margins and customer ties amid constrained fleet growth and market volatility. Increased market share and a focus on cost efficiency position TTS to capitalize on regional trade integration and forthcoming supply chain modernization trends.
View narrative
RON 4.21
FV
20.8% overvalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
3 months ago
author updated this narrative
Transcat
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Automation And OEM Disruption Will Erode Recurring Revenues
Key Takeaways Advances in automation and self-calibrating technologies threaten Transcat's recurring revenue by reducing demand for outsourced calibration services. Shifts toward in-house calibration and industry consolidation may pressure margins, shrink the addressable market, and constrain long-term earnings growth.
View narrative
US$85.00
FV
6.4% overvalued
intrinsic discount
7.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative
Sif Holding
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
New Maasvlakte Factory Ramp-Up Will Increase Production Capacity And Efficiency
Key Takeaways New factory ramp-up and improved safety culture are set to increase production capacity, reduce costs, and enhance revenue and margins. Strong order book and supply chain management may stabilize revenue, support EBITDA guidance, and protect against cost fluctuations.
View narrative
€14.50
FV
36.4% undervalued
intrinsic discount
24.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
3 days ago
author updated this narrative
Medistim
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding Healthcare Markets Will Offset Elevated Valuation Risks
Key Takeaways Strong growth, innovation, and pricing power are driving high investor expectations for sustained elevated sales and margin improvements despite risks of normalization and market shifts. Optimism about long-term leadership and recurring revenues may not fully account for emerging industry headwinds, evolving clinical practices, or technological disruption risks.
View narrative
NOK 230.00
FV
14.3% overvalued
intrinsic discount
8.60%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies